Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.42 |
| ▸ | LPL | P06858 | 6/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.36 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24239150 | 0.93 | ALOX5 (0.44) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL3862058 | 0.91 | ALOX5 (0.51) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL20109576 | 0.87 | LIPG (0.51) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL18018254 | 0.87 | LIPG (0.46) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL24239147 | 0.84 | LIPG (0.49) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL22248407 | 0.84 | ALOX5 (0.47) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL19533275 | 0.84 | ALOX5 (0.49) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL22087259 | 0.84 | ALOX5 (0.42) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL26435898 | 0.82 | ALOX5 (0.40) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL22045767 | 0.82 | LIPG (0.39) | LIPGLPLALOX5MEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20220037594-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | LIPG 1322/4885LPL 3264/4885ALOX5 624/4885 |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | LIPG 1225/4885LPL 2953/4885ALOX5 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.